mean ± SD | P-value | ||
---|---|---|---|
Overall | 6.80 ± 27.96 | ||
Age Groups | ≤70 years | 9.40 ± 34.94 | 0.090 |
> 70 years | 2.45 ± 5.10 | ||
Total gleason scoreª | 6 | 0.25 ± 1.60 | 0.001 |
7 | 1.55 ± 4.64 | ||
8 | 3.11 ± 5.46 | ||
9 | 24.92 ± 55.06 | ||
WHO grade groupª | Grade 1 | 0.25 ± 1.60 | 0.003 |
Grade 2 | 1.20 ± 4.15 | ||
Grade 3 | 3.75 ± 7.50 | ||
Grade 4 | 3.11 ± 5.46 | ||
Grade 5 | 24.92 ± 55.06 | ||
Tumor Quantificationª | < 10% | 0.52 ± 2.50 | 0.091 |
10–50% | 1.28 ± 4.26 | ||
> 50% | 12.00 ± 37.39 | ||
Perineural invasion | Present | 5.28 ± 6.77 | 0.643 |
Absent | 7.71 ± 35.01 | ||
Lymphovascular invasion | Present | 5.00 ± 0.00 | 0.910 |
Absent | 6.85 ± 28.31 | ||
Extraprostatic extension | Present | 0.00 ± 0.00 | 0.510 |
Absent | 7.21 ± 28.74 | ||
Seminal vesicle invasion | Present | 6.00 ± 6.92 | 0.954 |
Absent | 6.83 ± 28.41 |